ask="3.15"
ask_size="2000"
average_daily_volume="3628740"
bid="3.00"
bid_size="500"
book_value="-1.75"
change="-0.02"
change_from_200_day_moving_average="-1.62"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-5.86"
change_From_52_week_low="0.33"
change_in_percent="-0.63%"
close="3.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="113594000"
high="3.20"
high_52_weeks="9.02"
last_trade_date="2/21/2017"
last_trade_price="3.16"
last_trade_size="82851"
last_trade_time="4:00pm"
low="3.12"
low_52_weeks="2.83"
market_capitalization="409.58M"
moving_average_200_day="4.78"
moving_average_50_day="3.25"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.16"
pe_ratio="N/A"
peg_ratio="-0.49"
percent_change_from_200_day_moving_average="-33.94%"
percent_change_from_50_day_moving_average="-2.70%"
percent_change_from_52_week_high="-64.95%"
percent_change_from_52_week_low="+11.66%"
previous_close="3.18"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.95"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="4.68"
stock_exchange="NGM"
symbol="MACK"
volume="1643073"
weeks_range_52="2.83 - 9.02"
